Irreversible profound symptomatic bradycardia requiring pacemaker after tizanidine/loxoprofen combination therapy: a case report

J Int Med Res. 2018 Jun;46(6):2466-2469. doi: 10.1177/0300060518765009. Epub 2018 Mar 27.

Abstract

A 37-year-old man suffered irreversible profound symptomatic bradycardia requiring a pacemaker 3 days after beginning tizanidine/loxoprofen combination therapy for neck pain. This combination therapy is prescribed frequently for joint pain; however, combining loxoprofen with tizanidine could increase the risk of symptomatic bradycardia that is both permanent and severe. Similar cases have not been reported. This case suggests that tizanidine should be used cautiously when combined with loxoprofen, and drug interaction screening should be performed.

Keywords: Case report; bradycardia; loxoprofen; pacemaker; side effect; tizanidine.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Analgesics / adverse effects*
  • Analgesics / therapeutic use
  • Atrioventricular Block / chemically induced
  • Atrioventricular Block / therapy
  • Bradycardia / chemically induced
  • Bradycardia / therapy*
  • Cardiac Pacing, Artificial*
  • Clonidine / adverse effects
  • Clonidine / analogs & derivatives*
  • Clonidine / therapeutic use
  • Drug Therapy, Combination
  • Humans
  • Male
  • Neck Pain / drug therapy*
  • Phenylpropionates / adverse effects*
  • Phenylpropionates / therapeutic use

Substances

  • Analgesics
  • Phenylpropionates
  • loxoprofen
  • tizanidine
  • Clonidine